INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
INO on Nasdaq
Shares outstanding
66,729,680
Price per share
$1.74
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
20,711,886
Total reported value
$48,449,935
% of total 13F portfolios
0%
Share change
+10,542,261
Value change
+$25,433,676
Number of holders
98
Price from insider filings
$1.74
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% $19,200,995 9,846,664 FMR LLC 28 Nov 2025
JANUS HENDERSON GROUP PLC 10% +63% $12,999,275 +$6,630,068 6,666,295 +104% JANUS HENDERSON GROUP PLC 28 Nov 2025
Adage Capital Management, L.P. 10% $12,911,301 5,517,650 Adage Capital Management, L.P. 30 Sep 2025
Alyeska Investment Group, L.P. 7.5% $9,360,000 4,000,000 Alyeska Investment Group, L.P. 30 Sep 2025
HIGHBRIDGE CAPITAL MANAGEMENT LLC 9.2% $6,794,333 3,633,333 Highbridge Capital Management, LLC 31 Dec 2024
VANGUARD GROUP INC 5.5% +18% $3,794,153 +$664,546 2,028,959 +21% The Vanguard Group 31 Mar 2025
Stonepine Capital Management, LLC 3.8% -28% $2,683,444 -$900,721 1,434,997 -25% Stonepine Capital Management, LLC 31 Mar 2025
Deep Track Capital, LP 2.4% $3,076,623 1,314,796 Deep Track Capital, LP 30 Sep 2025
BlackRock, Inc. 1.5% -80% $1,099,608 -$3,642,379 537,627 -77% BlackRock, Inc. 30 Jun 2025

As of 30 Sep 2025, 98 institutional investors reported holding 20,711,886 shares of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO). This represents 31% of the company’s total 66,729,680 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) together control 30% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ADAGE CAPITAL PARTNERS GP, L.L.C. 5.1% 3,428,571 0.01% $8,022,856
JANUS HENDERSON GROUP PLC 4.9% 3,266,260 0% $7,626,717
VANGUARD GROUP INC 4.1% 2,712,872 +35% 0% $6,348,120
Boxer Capital Management, LLC 3.4% 2,300,000 1.7% $5,382,000
MILLENNIUM MANAGEMENT LLC 3% 1,972,518 +469% 0% $4,615,692
RENAISSANCE TECHNOLOGIES LLC 1.2% 816,339 +149% 0% $1,910,233
D. E. Shaw & Co., Inc. 1.2% 806,742 0% $1,887,776
MORGAN STANLEY 1.2% 786,774 +96% 0% $1,841,053
BANK OF AMERICA CORP /DE/ 0.95% 636,061 -50% 0% $1,488,383
GEODE CAPITAL MANAGEMENT, LLC 0.82% 546,747 +25% 0% $1,279,649
BlackRock, Inc. 0.75% 499,403 -7.1% 0% $1,168,603
GSA CAPITAL PARTNERS LLP 0.66% 443,104 +171% 0.09% $1,037,000
UBS Group AG 0.44% 293,062 +47% 0% $685,765
TWO SIGMA INVESTMENTS, LP 0.44% 290,800 +300% 0% $680,472
NORTHERN TRUST CORP 0.36% 238,471 -6.3% 0% $558,022
XTX Topco Ltd 0.32% 210,567 +855% 0.03% $492,727
STATE STREET CORP 0.28% 186,210 +51% 0% $435,731
ROYAL BANK OF CANADA 0.25% 165,408 +35% 0% $387,000
GMT CAPITAL CORP 0.19% 126,119 0% 0.01% $295,118
Headlands Technologies LLC 0.16% 110,068 +32464% 0.02% $257,559
TWO SIGMA ADVISERS, LP 0.16% 108,701 0% $254,360
JPMORGAN CHASE & CO 0.1% 65,206 +1667% 0% $152,583
HRT FINANCIAL LP 0.1% 65,065 -9.9% 0% $152,000
Concurrent Investment Advisors, LLC 0.08% 56,011 0% 0% $131,066
GOLDMAN SACHS GROUP INC 0.08% 53,711 -61% 0% $125,683

Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 103,072 $179,346 +$34,935 $1.74 7
2025 Q3 20,711,886 $48,449,935 +$25,433,676 $2.34 98
2025 Q2 10,168,502 $20,694,831 -$6,577,397 $2.04 101
2025 Q1 13,600,161 $22,159,691 +$51,992 $1.63 105
2024 Q4 13,346,624 $24,424,740 +$7,463,553 $1.83 100
2024 Q3 8,566,045 $49,511,575 +$2,096,827 $5.78 95
2024 Q2 8,056,972 $65,100,837 +$29,640,224 $8.08 92
2024 Q1 4,044,287 $56,123,192 +$53,680,856 $13.88 83
2023 Q4 298,900 $152,940 +$152,930 $0.51 7